APA (7th ed.) Citation

Miyamaru, S., Murakami, D., Nishimoto, K., & Orita, Y. Identifying factors for pembrolizumab eligibility in head and neck cancer. Springer.

Chicago Style (17th ed.) Citation

Miyamaru, Satoru, Daizo Murakami, Kohei Nishimoto, and Yorihisa Orita. Identifying Factors for Pembrolizumab Eligibility in Head and Neck Cancer. Springer.

MLA (9th ed.) Citation

Miyamaru, Satoru, et al. Identifying Factors for Pembrolizumab Eligibility in Head and Neck Cancer. Springer.